Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation, and this substantial upfront immunosuppression may result in serious complications, including cancer. METHODS. To characterize cancer risk in ILDKTr, we evaluated 858 ILDKTr and 12 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Motter, Jennifer D., Massie, Allan B., Garonzik-Wang, Jacqueline M., Pfeiffer, Ruth M., Yu, Kelly J., Segev, Dorry L., Engels, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365202/
https://www.ncbi.nlm.nih.gov/pubmed/37492080
http://dx.doi.org/10.1097/TXD.0000000000001505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365202/
https://www.ncbi.nlm.nih.gov/pubmed/37492080
http://dx.doi.org/10.1097/TXD.0000000000001505

Ejemplares similares